Serotonin(1B) receptor stimulation enhances dopamine-mediated reinforcement

Psychopharmacology

Volumn 128, Issue 2, 1996, Pages 150-160

  Parsons, Loren H ^a   Weiss, Friedbert ^a   Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

5 HT(1B) receptor; 8 OH DPAT; CGS 12066B; cocaine; GBR 12909; self administration

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 (4 METHYL 1 PIPERAZINYL) 7 TRIFLUOROMETHYLPYRROLO[1,2 A]QUINOXALINE; COCAINE; DOPAMINE UPTAKE INHIBITOR; SEROTONIN 1A AGONIST; SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR; VANOXERINE; NARCOTIC AGENT; PIPERAZINE DERIVATIVE; QUINOXALINE DERIVATIVE; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG POTENTIATION; DRUG SELF ADMINISTRATION; INSTRUMENTAL CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; WISTAR RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; COCAINE; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; NARCOTICS; PIPERAZINES; QUINOXALINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; SELF ADMINISTRATION; SEROTONIN AGONISTS;

EID: 0029657999     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050120     Document Type: Article

References (117)

1. Anderson PH (1989) The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur J Pharmacol 166:493-504
2. Aronson SC, Black JE, McDougle CJ, Scanley BE, Jatlow P, Kosten TR, Heninger GR, Price LH (1995) Serotonergic mechanisms of cocaine effects in humans. Psychopharmacology 119: 179-185
3. Arvidsson L-E, Hacksell U, Nilsson JLG, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstrom H (1981) 8-Hydroxy-2-(di-n-propylamino) tetralin, a new centrally acting 5-HT receptor agonist. J Med Chem 24:921-923
4. Azmitia EC, Segal M (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and median raphé nuclei of the rat. J Comp Neurol 179:641-668
5. Baker LE, Riddle EE, Saunders RB, Appel JB (1993) The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol 4:69-79
6. Baldo BA, Kelley AE (1991) Cross-sensitization between cocaine and GBR 12909, a dopamine uptake inhibitor. Brain Res Bull 27:105-108
7. 1a-mediated prolactin secretion in rats. Neurosci Lett 193:9-12
8. 2/1c agonist DOI. Biol Psychiatry 34:576-572
9. Beart PM, McDonald D (1982) 5-Hydroxytryptamine and 5-hydroxytryptaminergic-dopaminergic interactions in the ventral tegmental area of rat brain. J Pharm Pharmacol 34:591-593
10. Benloucif S, Galloway MP (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur J Pharmacol 200:1-8
11. Benloucif S, Keegan MJ, Galloway MP (1993) Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J Pharmacol Exp Ther 265:373-377
12. Berendsen HHG, Broekkamp, CLE (1990) Behavioral evidence for functional interactions between 5-HT-receptor subtypes in rats and mice. Br J Pharmacol 101:667-673
13. Bergman J, Madras BK, Johnson SE, Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155
14. Bhat RV, Baraban JM (1993) Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. J Pharmacol Exp Ther 267:496-505
15. 1a agonist gepirone: electrophysiological studies in the rat brain. Synapse 1:470-480
16. Boschert U, AitAmara D, Segu L, Hen R (1993) The mouse 5-hydroxytryptamine 1B receptor is localized predominantly on axon terminals. Neuroscience 58:167-182
17. Caine SB, Lintz R, Koob GF (1993) Intravenous drug self-administration techniques in animals. In: Sahgal A (ed) Behavioral neuroscience: a practical approach. Oxford University Press, Oxford, pp 117-143
18. 2C receptors. J Pharmacol Exp Ther 274:1414-1424
19. Cameron DL, Williams JT (1994) Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J Neurosci 14: 6763-6767
20. Carroll ME, Lac ST, Ascencio M, Kragh R (1990a) Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 35:237-244
21. Carroll ME, Lac ST, Ascencio M, Kragh R (1990b) Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan. Psychopharmacology 100:293-300
22. Cheetham SC, Heal DJ (1993) Evidence that RU 24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1b receptor. Br J Pharmacol 110:1621-1629
23. 1b iguanide increases dopamine release in the rat nucleus accumbens. Brain Res 543:354-357
24. 3 receptor activation in medial prefrontal cortex of freely moving rats. Synapse 10:264-266
25. Chen NH, Reith MEA (1994) Autoregulation and monoamine interactions in the ventral tegmental area in the absence and present of cocaine: a microdialysis study in freely moving rats. J Pharmacol Exp Ther 271:1597-1610
26. Chen NH, Reith MEA (1995) Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (±)-8-hydroxy-2-(di-n-propylamino)tetralin. J Neurochem 64:1585-1597
27. Colpaert FC, Niemegeers JE, Janssen AJ (1976) Cocaine cue in rats as it relates to subjective drug effects. Eur J Pharmacol 40:195-199
28. Colpaert FC, Niemegeers JE, Janssen AJ (1979) Discriminative stimulus properties of cocaine: neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol Biochem Behav 10:535-546
29. Conrad L, Leohard C, Pfaff D (1974) Connections of the median and dorsal raphé nuclei in the rat: an autoradiographic and degeneration study. J Comp Neurol 156:179-206
30. Crino PB, Vogt BA, Volicer L, Wiley RG (1990) Cellular localization of serotonin 1A, 1B and uptake sites in the cingulate cortex of the rat. J Pharmacol Exp Ther 252:651-656
31. Cunningham KA (1995) Modulation of serotonin function by acute and chronic cocaine: neurophysiological analyses. In: Hammer RP Jr (ed) The neurobiology of cocaine: cellular and molecular mechanisms. CRC Press, Boca Raton New York London Tokyo, pp 121-144
32. Cunningham KA, Callahan PM (1991) Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in rats. Psychopharmacology 104:177-180
33. Cunningham KA, Lakoski JM (1990) The interaction of cocaine with serotonin dorsal raphe neurons. Single-unit extracellular recording studies. Neuropsychopharmacology 3:41-50
34. Cunningham KA, Paris JM, Goeders NE (1992) Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding. Synapse 11:112-123
35. Davidson C, Stamford JA (1995) The effect of paroxetine on 5-HT efflux in the rat dorsal raphe nucleus is potentiated by both 5-HT-1A and 5-HT-1B/1D receptor antagonists. Neurosci Lett 188:41-44
36. Dourish CT, Hutson PH, Curzon G (1985) Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propyl-amino) tetralin (8-OH-DPAT). Brain Res Bull 15: 377-384
37. Emmett-Oglesby MW, Lane JD (1992) Tolerance to the reinforcing effects of cocaine. Behav Pharmacol 3:193-200
38. 1b binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 332:1-7
39. Frankfurt M, Medelson SD, McKittrick CR, McEwen BS (1993) Alterations of serotonin receptor binding in the rat hypothalamus following acute denervation. Brain Res 601:349-352
40. Galloway MP, Suchowski CS (1995) Effects of repeated cocaine exposure on 5-HT facilitation on DA release: microdialysis studies in vivo. Soc Neurosci Abstr 21:716
41. Galloway MP, Suchowski CS, Keegan MJ, Hjorth S (1993) Local infusion of the selective 5HT-1b agonist CP-93, 129 facilitates striatal dopamine release in vivo. Synapse 15:90-92
42. Glennon RA, Dukat M (1991) Serotonin receptors and their ligands: a lack of selective agents. Pharmacol Biochem Behav 40:1009-1017
43. Green AR, Guy AP, Gardner CR (1984) The behavioral effects of RU 24969, a suggested 5-HT-1B receptor agonist in rodents and the effect on the behavior of treatments with antidepressants. Neuropharmacology 23:655-661
44. Guan X-M, McBride WJ (1989) Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res Bull 23:541-547
45. 3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J Neurochem 44:1685-1696
46. Hamon M, Collin E, Chantrel D, Daval G, Verge D, Bourgoin S, Cresselin F (1990) Serotonin receptors and the modulation of pain. In: Besson JM (ed) Serotonin and pain. Elsevier, Amsterdam, pp 53-72
47. 1d receptor genes. Trends Pharmacol Sci 13:152-159
48. Heikkila RE, Manzino L (1984) Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake. Eur J Pharmacol 103:241-248
49. Hervé D, Pickel VM, Joh TH, Beaudet A (1987) Serotonin axon terminals in the ventral tegmental area of the rat: line structure and synaptic input to dopaminergic neurons. Brain Res 435:71-83
50. Howell LL, Byrd LD (1991) Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J Pharmacol Exp Ther 258: 178-185
51. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203
52. 1B receptors block the GABAB synaptic potential in rat dopamine neurons. J Neurosci 12:2000-2006
53. Kalivas PW, Duffy P (1990) The effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5:48-58
54. Katz JL, Griffiths JW, Sharpe LG, De Souza EB, Witkin JM (1993) Cocaine tolerance and cross-tolerance. J Pharmacol Exp Ther 264:183-192
55. 1 receptor agonists. Pharmacol Biochem Behav 45:577-587
56. Kleven MS, Anthony EW, Nielson EB, Woolverton WL (1988) Reinforcing and discriminative stimulus effects of GBR 12909 in rhesus monkeys. Soc Neurosci Abstr 14:305
57. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199:649-661
58. Koob GF (1992) Dopamine, addiction and reward. Semin Neurosci 4:139-148
59. Koob GF, Bloom FE (1988) Molecular and cellular mechanisms of drug dependence. Science 242:715-723
60. Kuhar ML, Ritz MC, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302
61. Lacosta S, Roberts DCS (1993) MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine. Pharmacol Biochem Behav 44:161-165
62. Layer RT, Uretsky NJ, Wallace LJ (1992) Effect of serotonergic agonists in the nucleus accumbens on d-amphetamine-stimulated locomotion. Life Sci 50:813-820
63. Levy AD, Baumann MH, Van de Kar LD (1994) Monoaminergic regulation of neuroendocrine function and its modification by cocaine. Frontiers Neuroendocrinol 15:85-156
64. Levy AD, Rittenhouse PA, Li Q, Bonadonna AM, Alvarez Sanz MC, Kerr JE, Bethea CL, Van de Kar LD (1992) Repeated injections of cocaine inhibit the serotonergic regulation of prolactin and renin secretion in rats. Brain Res 580:6-11
65. 1d in the rabbit and guinea-pig brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 343:353-364
66. Loh EA, Roberts DCS (1990) Break points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology 101:262-266
67. 1a receptors in the dorsal raphe nucleus. Eur J Pharmacol 149:9-15
68. 1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole. J Med Chem 3:2087-2093
69. 1b binding sites following 5,7-dihydroxytryptamine axotomy in the adult rat. Brain Res 623:345-348
70. 1b binding sites in the rat suprachiasmic nucleus. Brain Res 663:93-100
71. Markou A, Koob GF (1991) Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav 51:111-119
72. McGregor A, Lacosta S, Roberts DCS (1993) L-Tryptophan decreases the breaking point under a progressive ratio schedule of intravenous cocaine reinforcement in the rat. Pharmacol Biochem Behav 44:651-655
73. McKenna ML, Ho BT (1980) The role of dopamine in the discriminative stimulus properties of cocaine. Neuropharmacology 19:297-303
74. Melia KF, Spealman RD (1991) Pharmacological characterization of the discriminative-stimulus effects of GBR 12909. J Pharmacol Exp Ther 258:626-632
75. 1 receptor agonist, RU 24969, inhibits the efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5-HT autoreceptor. J Pharm Pharmacol 37:434-438
76. Middlemiss DN (1986) Blockade of the central 5-HT autoreceptor by β-adrenoceptor antagonists. Eur J Pharmacol 120:51-54
77. 1b receptors. Ann NY Acad Sci 600:132-148
78. Neale RF, Fallon SL, Boyar WC, Wasley WF, Martin LL, Stone GA, Glaeser BS, Sinton CM, Williams M (1987) Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonist. Eur J Pharmacol 136:1-9
79. Nissbrandt H, Waters N, Hjorth S (1992) The influence of serotonergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 346:12-19
80. Oberlander C, Blaquiere B, Pujol JF (1986) Distinct functions for dopamine and serotonin in locomotor behavior: evidence using the s-HT1 agonist RU 24969 in globus pallidus-lesioned rats. Neurosci Lett 67:113-118
81. 125]-iodocyanopindolol to measure 5-hydroxytryptamine-1B receptors in the brain of the rat. J Pharmacol Exp Ther 244:144-150
82. 1b receptors. Nature 360:161-163
83. 3H]5-hydroxytryptamine. Neuroscience 6:115-138
84. 3 antagonists do not alter the discriminative stimulus properties of cocaine. Psychopharmacology 104:475-478
85. 1B receptors. J Neurochem 60:380-383
86. Parsons LH, Justice JB, Jr (1993) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens of the rat as measured by in vivo microdialysis. Brain Res 606:195-199
87. Parsons LH, Koob GF, Weiss F (1995) Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther 274:1182-1191
88. 3 antagonist, fails to alter cocaine self-administration in rats. Pharmacol Biochem Behav 39:133-136
89. Peltier R, Schenk S (1993) Effects of serotonergic manipulations on cocaine self-administration in rats. Psychopharmacology 110:390-394
90. Peltier RL, Emmett-Oglesby MW, Thomas WH, Schenk S (1994) Failure of ritanserin to block the discriminative stimulus or reinforcing effects of cocaine. Pharmacol Biochem Behav 48:473-478
91. Pettit HO, Pan HT, Parsons LH, Justice JB, Jr (1990) Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J Neurochem 55: 798-804
92. Phelix CF, Broderick PA (1995) Light microscopic immunocytochemical evidence of converging serotonin and dopamine terminals in ventrolateral nucleus accumbens. Brain Res Bull 37:37-40
93. Pineyro G, Montigny C, Blier P (1995) 5-HT-1D receptors regulate 5-HT release in the rat raphe nuclei: in vivo voltammetry and in vitro superfusion studies. Neuropsychopharmacol 13:249-260
94. 1b receptor binding sites in the central nervous system. Neuropsychopharmacology 10:259-264
95. Richardson NR, Roberts DCS (1991) Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration. Life Sci 49:833-840
96. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223
97. Roberts DCS (1993) Self-administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats. Psychopharmaco logy 111:202-206
98. Roberts DCS, Corcoran ME, Fibiger HC (1977) On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 6:615-620
99. Roberts DCS, Koob GF, Klonoff P, Fibiger HC (1980) Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav 12:781-787
100. Rompré P-P, Bauco P (1990) GBR 12909 reverses the SCH 23390 inhibition of rewarding effects of brain stimulation. Eur J Pharmacol 182:181-184
101. 3H] carboxymethoxy-3 beta-(4-fluorophenyl)tropane to the serotonin transporter. Mol Pharmacol 40:421-426
102. Satel SL, Krystal JH, Delgado PL, Kosten TR, Charmey DS (1995) Tryptophan depletion and attenuation of cue-induced craving for cocaine. Am J Psychiatry 152:778-783
103. 1b receptors display altered behavioral responses to cocaine. Soc Neurosci Abstr 21:715
104. 1B ligands exist? Naunyn-Schmiedeberg's Arch Pharmacol 339:675-683
105. Spealman RD (1993) Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology 112:93-99
106. 1 receptor agonist, RU 24969, in the rat. Neuropharmacology 8:877-886
107. Van de Kar LD, Carnes M, Maslowski RJ, Bonadonna AM, Rittenhouse PA, Kunimoto K, Peichowski RA, Bethea CL (1989) Neuroendocrine evidence for denervation supersensitivity of serotonin receptors. Effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion. J Pharmacol Exp Ther 251:428-434
108. 1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci 6:4373-4382
109. Weiss F, Parsons LH, Markou A (1995) Neurochemistry of cocaine withdrawal. In: Hammer RP Jr (ed) The neurobiology of cocaine: cellular and molecular mechanisms. CRC Press, Boca Raton New York London Tokyo, pp 163-180
110. Weissmann D, Mach E, Oberlander C, Demassey Y, Pujol JF (1986) Evidence for hypersensitivity of 5-HT1b binding sites in the substantia nigra of the rat after 5.7-dihydroxytryptamine intraventricular injection. Neurochem Int 9:191-200
111. White FJ, Hu X-T, Henry DJ (1993) Electrophysiological effects of cocaine in the rat nucleus accumbens: microiontophoretic studies. J Pharmacol Exp Ther 266:1075-1084
112. White FJ, Hu X-T, Henry DJ, Zhang X-F (1995) Neurophysiological alterations in the mesocorticolimbic dopamine system with repeated cocaine administration. In: Hammer RP Jr (ed) The neurobiology of cocaine: cellular and molecular mechanisms. CRC Press, Boca Raton New York London Tokyo, pp 99-120
113. Winters TA, Slifer BL (1989) Discriminative stimulus properties of cocaine: is there mediation by serotonin? FASEB J 3:295
114. Wise RA (1984) Neural mechanisms of the reinforcing action of cocaine. In: Grabowski J (ed) Cocaine: pharmacology, effects, and treatment of abuse (NIDA Research Monograph Series, vol. 50). United States Government Printing Office, pp 15-33
115. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492
116. Witkin JM, Nichols DE, Terry P, Katz JL (1991) Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257:706-713
117. Yadid G, Pacak K, Kopin IJ, Goldstein DS (1994) Endogenous serotonin stimulates striatal dopamine release in conscious rats. J Pharmacol Exp Ther 270:1158-1165